Thursday, 5 November 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 27, 2026

FTSE 100 LIVE: Stocks slump as Trump’s Iran strike delay fails to lift mood

View original at uk.finance.yahoo.com
FTSE 100 LIVE: Stocks slump as Trump’s Iran strike delay fails to lift mood The FTSE 100 (^FTSE) and European stocks headed lower on Friday, as traders shrugged off Donald Trump’s latest pause on striking Iran’s energy infrastructure, which failed to provide a meaningful boost to market sentiment…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Another decline for UK vehicle production and exports is extremely worrying, given these figures pre-date the crisis in the Middle East

    60% confidence
  • Poor weather may have played a role in February's weaker retail sales, but the bigger issue is that underlying demand still looks fragile. Our latest consumer research shows 52% of UK consumers continue to cite inflation as a top concern, and only 23% are optimistic about economic conditions. The pressure is also clear in planned spending. In the UK, 50% of consumers say they expect to spend less on furniture over the next three months, versus just 15% who expect to spend more, with similar patterns across apparel and home electronics. That suggests this is about more than a one-month weather effect, but instead a broad-based volume recovery still has not emerged.

    60% confidence
  • Gold net purchases estimated to grow to 900 tonnes in 2026

    60% confidence
  • The incident was caused by a software defect from an overnight IT update. No customers have so far been identified as suffering financial losses as a result.

    60% confidence
  • While the rhetoric around de-escalation and dialogue is certainly preferable to outright conflict, the market appears to be growing increasingly numb to President Trump's verbal reassurances. By extending the deadline, it effectively kicks the can down the road, pushing back any concrete resolution regarding the reopening of the Strait of Hormuz. This, in turn, simply extends the uncertainty weighing on markets and the broader global economy.

    60% confidence
  • Survey showed people are concerned about the prospects for inflation and the economy. The sharp rise in energy prices caused by the effective closure of the Strait of Hormuz and attacks on infrastructure in the region has led to fears of higher inflation and weaker growth across oil-importing countries

    60% confidence
  • Commented on UK retail sales decline

    60% confidence
  • I've not heard from Elon, but my phone line is still open and I'm holding out hope that I get a call

    60% confidence
  • Commented on mortgage rate increases related to Middle East conflict

    60% confidence
  • Statement regarding CMA investigations into online reviews ecosystem

    60% confidence
  • Iran denied it was begging to make a deal, despite Trump's earlier claims

    60% confidence
  • Pausing the period of Energy Plant destruction by 10 Days to Monday, April 6, 2026, at 8 P.M., Eastern Time. Talks are ongoing and, despite erroneous statements to the contrary by the Fake News Media, and others, they are going very well.

    60% confidence
  • Apologized for the IT glitch data breach incident on behalf of Lloyds Banking Group

    60% confidence

Data points we hold from this source

NASDAQ · percent change-2.4 percent
Dow Jones Industrial Average · percent change-1.0 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com